Half of Three Oral Antidiabetic Drugs as a Regimen for Treatment of Type 2 Diabetes Mellitus Patients in Low-income Populations
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 24, Issue 9
Abstract
There is a progressive increase in the number of patients developing type 2 diabetes mellitus (T2DM), worldwide. Several classes of antidiabetic drugs are available. Metformin is a biguanide with many pleiotropic effects in addition to decreasing hyperglycemia. Dipeptidyl-peptidase 4 (DPP4) inhibitors are a group of medications used as glucose-lowering agents in T2DM.The combination of metformin plus DPP4 inhibitors have an additive effect on improving HbA1c level but of high cost, especially in low-income countries like Egypt. So, the aim of this study is to assess the efficacy and safety of adding sulphonylureas (e.g, glimepiride or gliclazide) to half the dose of a DPP4 inhibitor /metformin combinations compared to using the full dose of this DPP4 inhibitor /metformin combination in T2DM. Materials and Methods: This prospective study was conducted on186 patients with type 2 diabetes mellitus (T2DM), who achieved glycemic targets on DPP4 inhibitor (sitagliptin or vildagliptin) 50 m /metformin 1000 mg, twice daily fixed-dose combination. The enrolled subjects were then divided into 2 groups. Group1 were 92 patients continued on the same regimen. Group 2 (patient who could not afford the high cost of the DPP4 inhibitors) shifted to half the dose of the DPP4 inhibitor / metformin plus a dose of sulphonylureas (SU) either Glimepiride (4 mg) or Gliclazide (60 mg slow release form) once daily. For both groups: weight, fasting blood glucose (FBG), 2 hours postprandial glucose (2 hrs PPG), and glycated hemoglobin (HbA1c), were measured at the start and after 12 weeks of the study. Results: There were a decrease in FBG, 2hs PPG, and HA1c with an increase in weight and in the mean number of hypoglycemic episodes per patient among participants shifted to half the dose of DPP4 inhibitor /metformin with an added dose of SU compared to the other group of patients continued on the full dose of the same DPP4 inhibitor /metformin combination. Conclusion: Adding sulphonylureas (either glimepiride or gliclazide) to half the dose of a DPP4 inhibitor/metformin combination is non-inferior to using the full dose of this DDP 4 inhibitor/metformin combination twice daily in T2DM patients with low risk of hypoglycemia. This regimen may be effective and safe for low-income populations like Egypt.
Authors and Affiliations
Mohamed A. Mashahit, Eman M. Ezzat, Ahmed A. Hammad
Keywords
Related Articles
- EP ID EP312617
- DOI 10.9734/JAMMR/2017/37656
- Views 71
- Downloads 0
Why is Perinatal Mortality Higher among Women Delivered at Health Facility in Rural Northwest Ethiopia? A Qualitative Study
This study investigated the reasons for high perinatal deaths among newborns delivered in health facilities in rural northwest Ethiopia. Qualitative in-depth interviews were conducted with 11 survivors of obstetric compl...
Antiatherogenic, Hypolipidemic and Antiinflammatory Benefits of Black Tea and Zanthoxylum Zanthoxyloid
The use of medicinal plants in the treatment of ailments is increasing around the globe. This study assessed the antihyperlipidemic and antiatherogenic benefits of black tea (BT) and Z. zanthoxylum (Zz) in rats. Thirty t...
A Rare Case of IgA-mediated Autoimmune Hemolytic Anemia in a Young Adult
A 21-year-old previously healthy male presented with unexplained intravascular hemolysis. Patient had anemia, elevated serum indirect bilirubin, elevated LDH, reticulocytosis, decreased haptoglobin and spherocytosis. Ini...
Prognostic Implications of Expression of the Wilms Tumor 1 (WT1) Gene in Acute Leukemia (Experience from South Egypt)
Background: Wilms’ tumor (WT1) gene expression has been reported in the majority of acute leukemia patients at diagnosis and has been evaluated as a prognostic and minimal residual disease (MRD) marker but its role is st...
In vitro Study of Interactions of Sildenafil Citrate with Bovine Serum Albumin in Presence of Bisoprolol Fumarate and Metformin Hydrochloride by Fluorescence Spectrophotometry
Aims: This paper describes the In vitro study of protein binding by sildenafil citrate (SC) in presence of bisoprololfumarate (BF) and metformin hydrochloride (MH). Study Design: Study was designed to assess In vitro of...